LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported that independent industry analysts have r…
Tenpoint Therapeutics, Ltd. to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
LONDON & SEATTLE–(BUSINESS WIRE)–Tenpoint Therapeutics, Ltd., a global, commercial-ready biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today announced that Henric Bjarke, Chief Executive …
Secukinumab Fails to Show Benefit in Graves’ Orbitopathy
Secukinumab does not show greater clinical efficacy than placebo in patients with moderate-to-severe Graves’ orbitopathy, according to the ORBIT study. Medscape News UK
Uncategorized
Dompé Doses First Patients in Europe and US in Phase 3 Study of Isocyclosporin for Atopic Keratoconjunctivitis
MILAN & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé advances a novel, dual-inhibitor into Phase 3 for AKC, a chronic inflammatory eye disease with no FDA-approved treatment options.
Uncategorized
Glaukos Announces Participation in J.P. Morgan Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Levodopa May Help Prevent Progression to Neovascular AMD
A new study shows that in patients with intermediate nonneovascular age-related macular degeneration, levodopa treatment is linked to a lower risk of developing the neovascular form of the disease. Medscape Medical News